Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Requip® 0.25 mg Tablets
DRUG
2 trials
Sponsors
Teva Pharmaceuticals USA
Conditions
Healthy
Phase 1
Ropinirole 0.25 mg Tablets Under Fasting Conditions
Completed
NCT00829504
Teva Pharmaceuticals USA
Healthy
Start: 2004-10-31
End: 2004-10-31
Updated: 2009-09-11
The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions
Completed
NCT00830219
Teva Pharmaceuticals USA
Healthy
Start: 2004-11-30
End: 2004-11-30
Updated: 2009-09-15